B
Braidwell Portfolio holdings
AUM
$2.92B
1-Year Est. Return
4.59%
1 Year Est. Return
-4.59%
AUM
$2.84B
AUM Growth
-$528M
(-16%)
Holding
86
Top Buys
| 1 | +$63.4M | |
| 2 | +$47.4M | |
| 3 | +$42.5M | |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
+$38.9M |
| 5 |
Krystal Biotech
KRYS
|
+$36.1M |
Top Sells
| 1 | +$64.8M | |
| 2 | +$43.2M | |
| 3 | +$39.6M | |
| 4 |
BioNTech
BNTX
|
+$35.3M |
| 5 |
Kiniksa Pharmaceuticals
KNSA
|
+$33.1M |
Sector Composition
| 1 | Healthcare | 67.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Neurocrine Biosciences
NBIX
$15.2B
| $132M | 4.63% |
1,191,925
+290,135
|
|
||
2
Legend Biotech
LEGN
$5.87B
| $101M | 3.55% |
2,977,951
|
|
||
3
argenx
ARGX
$52.6B
| $95.2M | 3.35% |
160,849
+80,083
|
|
||
4
Xenon Pharmaceuticals
XENE
$2.96B
| $90.9M | 3.2% |
2,709,875
-204,089
|
|
||
5
Align Technology
ALGN
$9.67B
| $84.3M | 2.96% |
530,530
+155,351
|
|
||
6
CG Oncology
CGON
$3.03B
| $80.4M | 2.83% |
3,283,317
|
|
||
|
7
Krystal Biotech
KRYS
$5.73B
| $72.3M | 2.54% |
400,744
+200,244
|
|
||
8
Thermo Fisher Scientific
TMO
$215B
| $63.6M | 2.23% |
127,733
+37,979
|
|
||
9
Danaher
DHR
$148B
| $63.4M | 2.23% |
+309,339
|
|
||
10
Glaukos
GKOS
$4.82B
| $61.5M | 2.16% |
624,435
+335,559
|
|
||
11
Nuvalent
NUVL
$6.79B
| $59.6M | 2.1% |
840,945
+599,710
|
|
||
12
iRhythm Technologies
IRTC
$5.63B
| $58.2M | 2.05% |
556,391
-149,000
|
|
||
13
Apogee Therapeutics
APGE
$3.7B
| $57.5M | 2.02% |
1,540,362
|
|
||
14
Transmedics
TMDX
$4.07B
| $57.5M | 2.02% |
854,884
-67,216
|
|
||
15
Guardant Health
GH
$12.2B
| $56.5M | 1.99% |
1,327,327
-1,520,604
|
|
||
16
Edgewise Therapeutics
EWTX
$1.81B
| $54.1M | 1.9% |
2,458,808
+126,612
|
|
||
17
Inspire Medical Systems
INSP
$2.38B
| $48.2M | 1.69% |
302,410
+9,000
|
|
||
|
18
Kiniksa Pharmaceuticals
KNSA
$2.91B
| $43.6M | 1.53% |
1,962,909
-1,489,538
|
|
||
19
Intuitive Surgical
ISRG
$199B
| $43.6M | 1.53% |
88,000
+12,700
|
|
||
20
Alphatec Holdings
ATEC
$2.94B
| $43.2M | 1.52% |
4,259,429
+2,939
|
|
||
21
Spyre Therapeutics
SYRE
$1.75B
| $41.6M | 1.46% |
2,578,404
|
|
||
|
BPMC
22
DELISTED
Blueprint Medicines
BPMC
| $38.9M | 1.37% |
+439,968
|
|
||
23
Dyne Therapeutics
DYN
$2.62B
| $37.9M | 1.33% |
3,621,344
+2,940,162
|
|
||
24
Apellis Pharmaceuticals
APLS
$2.44B
| $36.1M | 1.27% |
1,652,334
-446,532
|
|
||
25
Adaptive Biotechnologies
ADPT
$2.26B
| $35.7M | 1.25% |
+4,803,794
|
|